Table 2.
Prevalence of active and latent MTrPs in patients with knee osteoarthritis (KOA)
| Muscle | DNG -LMTrPs | DNG -AMTrPs | DG-LMTrPs | DG-AMTrPs | ||||
|---|---|---|---|---|---|---|---|---|
| Number (42) | Percentage(%) | Number (42) | Percentage (%) | Number (35) | Percentage (%) | Number (35) | Percentage (%) | |
| rectus femoris | 21 | 50% | 16 | 38.1% | 19 | 54.3% | 14 | 40% |
| vastus medialis | 19 | 45% | 13 | 31% | 18 | 51.4% | 12 | 34.2% |
| vastus lateralis | 27 | 64% | 23 | 54.8% | 20 | 57.1% | 17 | 48.6% |
| tensor fasciae latae | 15 | 42.9% | 9 | 21.4% | 12 | 34.3% | 7 | 20% |
| hip adductors | 17 | 40.5% | 10 | 23.8% | 10 | 28.6% | 6 | 17.1% |
| gluteus maximus | 7 | 16.7% | 3 | 7.1% | 4 | 11.4% | 2 | 5.7% |
| gluteus medius | 10 | 23.8% | 7 | 16.7% | 11 | 31.4% | 6 | 17.1% |
| biceps femoris | 23 | 54.8% | 20 | 47.6% | 18 | 51.4% | 14 | 40% |
| Semitendinosus- semimembranosus | 12 | 28.6% | 5 | 11.9% | 7 | 20% | 3 | 8.6% |
| popliteus | 18 | 42.9% | 12 | 28.6% | 12 | 34.3% | 8 | 22.6% |
| gastrocnemius | 30 | 71.4% | 21 | 50% | 23 | 65.7% | 16 | 45.7% |
| soleus muscle | 20 | 47.6% | 14 | 33.3% | 17 | 48.6% | 12 | 34.3% |
Abbreviations: DNG dry needling group, DG Diclofenac group, LMTrPs latent myofascial trigger point, AMTrPs active myofascial trigger points